StockPriceToday
Exelon Corp (EXC)
About Exelon Corp
Exelon Corporation operates as a regulated utility services company that provides electricity and natural gas delivery to millions of customers across Illinois, Pennsylvania, Maryland, New Jersey, Delaware, and Washington D.C. The company's regulated utility operations have made EXC stock price sensitive to regulatory decisions and energy market trends.
Exelon's electric utilities operate transmission and distribution networks that deliver electricity to residential, commercial, and industrial customers in major metropolitan areas. The company's natural gas utilities provide distribution services in Pennsylvania and other markets.
The company's focus on grid modernization, renewable energy integration, and customer service improvements aligns with evolving energy industry requirements. Exelon's investments in clean energy and infrastructure upgrades position it well for the energy transition, influencing EXC stock price movements.
Exelon's regulated utility model provides stable cash flows and dividend income while its strategic initiatives address changing energy needs. The company's ability to manage regulatory relationships while investing in grid infrastructure remains important for its continued success and shareholder returns.
EXC Stock 12 Month Chart
Latest News for EXC
Even though Exelon has lagged behind the broader Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.
Exelon ( ($EXC) ) has issued an update. On December 4, 2025, Exelon Corporation completed the sale of $1 billion in Convertible Senior Notes due ...
Exelon Corporation (EXC) has announced the pricing of its offering of $900 million in aggregate principal amount of 3.25% convertible senior notes due in 2029. The company has granted the initial purc ...
Other Popular Stocks
Old Dominion Freight Line Inc. operates as a less-than-truckload motor carrier providing regional, inter-regional, and national LTL services in the United States.
REGENXBIO Inc. (RGNX) is a leading clinical-stage biotechnology company developing gene therapy treatments for serious diseases using its proprietary NAV Technology Platform based on...
Cabaletta Bio Inc. is a biotechnology company developing engineered T-cell therapies for autoimmune diseases.